RAC Race identifies 39 new molecules with potential to inhibit cancer-associated protein Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University in Melbourne Caroline Smith 13 hours ago ASX News Healthcare Biotechnology
STP Radiopharm extends radioimmunotherapy trial to 5 more cancer types Radiopharm Theranostics Ltd has received approval to extend its Phase 1 trial of Lu-RAD204 to five more cancer types Caroline Smith 2 days ago ASX News Healthcare Biotechnology
STP Smallcap Radiopharm notches +12% jump on pancreatic cancer imaging win Radiopharm Theranostics (ASX:RAD) has seen the safety profile of its pancreatic cancer imaging drug RAD 301 boosted by a published study. Jonathon Davidson 4 days ago ASX News Healthcare Biotechnology
ACW Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial Actinogen Medical Ltd has received a $9M R&D rebate from the Australian Taxation Office which will fund its activities through to mid-2026 Caroline Smith 12 Nov 2024 13:41 (AEDT) ASX News Healthcare Biotechnology
INA Imugene kicks off Australian trial for blood cancer treatment Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test CAR T cell therapy azer-cel Caroline Smith 08 Nov 2024 13:33 (AEDT) ASX News Healthcare Biotechnology
PYC PYC Therapeutics moves into final stage of child blindness study PYC has been approved to escalate doses of its drug candidate VP-001, treating Retinitis Pigmentosa 11, in a second patient cohort. Jonathon Davidson 05 Nov 2024 09:52 (AEDT) ASX News Healthcare Biotechnology
DUB Dimerix links up with US NEPTUNE network to boost recruitment for FSGS study Dimerix Ltd is set to partner with a key research network at the University of Michigan which should boost recruitment Caroline Smith 01 Nov 2024 16:19 (AEDT) ASX News Healthcare Biotechnology
PYC Biotech stock PYC doses first patient in rare blindness-causing disease trial PYC has dosed its first patient in a clinical trial seeking to ameliorate symptoms of Autosomal Dominant Optic Atrophy (ADAO). Jonathon Davidson 01 Nov 2024 12:08 (AEDT) ASX News Healthcare Biotechnology
OAR Orthocell raising $17M in placement to fund US launch of Remplir Orthocell (ASX:OCC) has announced its receipt of commitments for $17M in funding via placement to bankroll the US launch of Remplir. Jonathon Davidson 25 Oct 2024 10:44 (AEDT) ASX News Healthcare Biotechnology
TLX Telix Pharmaceuticals' quarterly revenue exceeds AU$200M Telix Pharmaceuticals (ASX:TLX) reveals its quarterly revenues while also reaffirming its full-year 2024 revenue guidance. Jocelyn Aspa 18 Oct 2024 07:00 (AEDT) ASX News Healthcare Biotechnology
OAR Orthocell wins first international approval for nerve repair product West Australia-based regenerative medicine play Orthocell (ASX: OCC) has received regulatory approval from the Health Sciences Authority in Singapore. Sean Boss 08 Oct 2024 15:04 (AEDT) ASX News Healthcare Biotechnology
SHN Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial. Jonathon Davidson 07 Oct 2024 11:17 (AEDT) ASX News Healthcare Biotechnology
MSB Cashed up & ready to go: Mesoblast forges funding deal with top shareholder Mesoblast (ASX:MSB) is trading up more than 1.75% after striking a funding deal with its largest shareholder Gregory George for AUD$72.7 million in convertible notes. Sonia Madigan 30 Sep 2024 11:20 (AEST) ASX News Healthcare Biotechnology
